September 20, 2016
The Conscience of Antimicrobial Resistance Accountability (CARA) is an alliance to support the United Nations Resolution on Antimicrobial Resistance
WASHINGTON, D.C. - Nine founding organizations have launched CARA—the Conscience of Antimicrobial Resistance Accountability—an alliance formed in anticipation of the Resolution to be introduced at the UN General Assembly High-Level Meeting on Antimicrobial Resistance. More organizations from the public and private sectors around the world are expected to join in the coming months.
CARA members will work to hold the United Nations and other international bodies, national governments, the private sector, and civil society to the commitments they have made to ensure sustainable access to effective antimicrobials.
The goals of the alliance include improving the surveillance of antibiotic use and resistance; preserving the effectiveness of antibiotics through conservation; ensuring universal access to antibiotics, particularly in lower-income countries, where access is currently inadequate; supporting innovation to encourage the development of new antimicrobials, compounds to boost their effectiveness, diagnostics to better diagnose infections, and vaccines to prevent infections from occurring; and accountability to hold the relevant agencies to their goals.
CARA also expects to adopt clear, quantitative targets for meeting these general goals and reporting regularly on progress, including celebrating successes, recommending solutions to problems and identifying where more effort is needed.
The organization will collaboratively develop a plan for its first five years, with members committing to undertake specific and appropriate activities for their own organizations and countries, consistent with specific goals set by the alliance.
CARA’s founding organizations are
- Antibiotic Resistance Action Center (ARAC), the George Washington University
- British Society for Antimicrobial Chemotherapy (BSAC)
- Center for Disease Dynamics, Economics & Policy (CDDEP)
- Center for Global Development (CGD)
- Center for Infectious Disease Research and Policy (CIDRAP)
- German Center for Infection Research (DZIF)
- The Pew Charitable Trusts
- Norwegian Institute of Public Health (NIPH)
- World Alliance Against Antibiotic Resistance (WAAAR)
Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy, one of the founding organizations, said, “Increasing resistance threatens the health of the global population. The U.N. Resolution on Antimicrobial Resistance will usher in a new era of global involvement to maintain the effectiveness of antibiotics and ensure reliable access. It is our responsibility to act as the conscience of the public sector, private sector, and civil society organizations, to ensure that they are carrying out the responsibilities that have been established in this resolution.”
About the Center for Disease Dynamics, Economics & Policy
The Center for Disease Dynamics, Economics & Policy (CDDEP) produces independent, multidisciplinary research to advance the health and wellbeing of human populations around the world. CDDEP projects are global in scope, spanning Africa, Asia, and North America and include scientific studies and policy engagement. The CDDEP team is experienced in addressing country-specific and regional issues, as well as the local and global aspects of global challenges, such as antibiotic resistance and pandemic influenza. CDDEP research is notable for innovative approaches to design and analysis, which are shared widely through publications, presentations and web-based programs. CDDEP has offices in Washington, D.C. and New Delhi and relies on a distinguished team of scientists, public health experts and economists.